151 related articles for article (PubMed ID: 17369114)
21. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort.
Frøslie KF; Jahnsen J; Moum BA; Vatn MH;
Gastroenterology; 2007 Aug; 133(2):412-22. PubMed ID: 17681162
[TBL] [Abstract][Full Text] [Related]
22. A 5-year prospective observational study of the outcomes of international treatment guidelines for Crohn's disease.
Cullen G; Keegan D; Mulcahy HE; O'Donoghue DP
Clin Gastroenterol Hepatol; 2009 Mar; 7(3):323-8; quiz 252. PubMed ID: 19174193
[TBL] [Abstract][Full Text] [Related]
23. Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas?
Gaertner WB; Decanini A; Mellgren A; Lowry AC; Goldberg SM; Madoff RD; Spencer MP
Dis Colon Rectum; 2007 Nov; 50(11):1754-60. PubMed ID: 17899271
[TBL] [Abstract][Full Text] [Related]
24. Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease?
Polymeros D; Bogdanos DP; Day R; Arioli D; Vergani D; Forbes A
Gastroenterology; 2006 Jul; 131(1):85-96. PubMed ID: 16831593
[TBL] [Abstract][Full Text] [Related]
25. [Mycobacterium avium subsp. paratuberculosis in food and its relationship with Crohn's disease].
Cirone K; Morsella C; Romano M; Paolicchi F
Rev Argent Microbiol; 2007; 39(1):57-68. PubMed ID: 17585661
[TBL] [Abstract][Full Text] [Related]
26. JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy?
Verbeeck J; Van Assche G; Ryding J; Wollants E; Rans K; Vermeire S; Pourkarim MR; Noman M; Dillner J; Van Ranst M; Rutgeerts P
Gut; 2008 Oct; 57(10):1393-7. PubMed ID: 18436577
[TBL] [Abstract][Full Text] [Related]
27. Pathogenic agents in inflammatory bowel diseases.
Pineton de Chambrun G; Colombel JF; Poulain D; Darfeuille-Michaud A
Curr Opin Gastroenterol; 2008 Jul; 24(4):440-7. PubMed ID: 18622157
[TBL] [Abstract][Full Text] [Related]
28. [Paratuberculose enteritis and Crohn's disease].
Suárez Fernández G
An R Acad Nac Med (Madr); 2007; 124(2):221-34; discussion 234-40. PubMed ID: 18069597
[TBL] [Abstract][Full Text] [Related]
29. The etiology of Mycobacterium avium subspecies paratuberculosis in Crohn's disease.
Alluwaimi AM
Saudi Med J; 2007 Oct; 28(10):1479-84. PubMed ID: 17914503
[TBL] [Abstract][Full Text] [Related]
30. The mycobacteria story in Crohn's disease.
Shanahan F; O'Mahony J
Am J Gastroenterol; 2005 Jul; 100(7):1537-8. PubMed ID: 15984977
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment of a Crohn's disease patient infected with bacteremic Mycobacterium paratuberculosis.
Chamberlin W; Ghobrial G; Chehtane M; Naser SA
Am J Gastroenterol; 2007 Mar; 102(3):689-91. PubMed ID: 17335456
[No Abstract] [Full Text] [Related]
32. Cheilitis granulomatosa and Melkersson-Rosenthal syndrome: evaluation of gastrointestinal involvement and therapeutic regimens in a series of 14 patients.
Ratzinger G; Sepp N; Vogetseder W; Tilg H
J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1065-70. PubMed ID: 17714126
[TBL] [Abstract][Full Text] [Related]
33. Experimental study on the use of intravenous immunoglobulin (IVIg) in patients with steroid-resistant Crohn's disease.
Chrissafidou A; Malek M; Musch E
Z Gastroenterol; 2007 Jul; 45(7):605-8. PubMed ID: 17620224
[TBL] [Abstract][Full Text] [Related]
34. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
Charpignon C; Beau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):153-7. PubMed ID: 18343615
[TBL] [Abstract][Full Text] [Related]
35. [Crohn's disease surgery: problems of postoperative recurrence].
Fornaro R; Frascio M; Stabilini C; Sticchi C; Barberis A; Denegri A; Ricci B; Azzinnaro A; Lazzara F; Gianetta E
Chir Ital; 2008; 60(6):761-81. PubMed ID: 19256268
[TBL] [Abstract][Full Text] [Related]
36. [Role of Mycobacterium avium paratuberculosis in the etiopathogenesis of Crohn's disease].
Ormaechea JI; Gisbert JP; Marín-Jiménez I
Gastroenterol Hepatol; 2009 May; 32(5):353-63. PubMed ID: 19457586
[No Abstract] [Full Text] [Related]
37. Matrix metalloproteinase 9 is involved in Crohn's disease-associated platelet hyperactivation through the release of soluble CD40 ligand.
Menchén L; Marín-Jiménez I; Arias-Salgado EG; Fontela T; Hernández-Sampelayo P; Rodríguez MC; Butta NV
Gut; 2009 Jul; 58(7):920-8. PubMed ID: 19039088
[TBL] [Abstract][Full Text] [Related]
38. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
Nathan DM; Iser JH; Gibson PR
J Gastroenterol Hepatol; 2008 Jun; 23(6):954-8. PubMed ID: 17559377
[TBL] [Abstract][Full Text] [Related]
39. Cows, Crohn's and more: is Mycobacterium paratuberculosis a superantigen?
Thomas Dow C
Med Hypotheses; 2008 Dec; 71(6):858-61. PubMed ID: 18789596
[TBL] [Abstract][Full Text] [Related]
40. Long-term quality of life in patients with Crohn's disease and perianal fistulas: influence of fecal diversion.
Kasparek MS; Glatzle J; Temeltcheva T; Mueller MH; Koenigsrainer A; Kreis ME
Dis Colon Rectum; 2007 Dec; 50(12):2067-74. PubMed ID: 17680311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
